USADA files charges against Lance Armstrong
The US Anti-Doping Agency has filed formal charges against Lance Armstrong, accusing the seven-time Tour de France winner of using performance-enhancing drugs.
Armstrong, his former team manager Johan Bruyneel and other associates were notified of the charges in a letter on Friday.
A statement from USADA CEO Travis T Tygart said: "USADA can confirm that the independent three person Anti-Doping Review Board (ADRB) has conducted a full evaluation and has made a unanimous recommendation to move forward with the adjudication process in accordance with the rules.
"All respondents will have the opportunity to exercise their right to a full public arbitration hearing, should they so choose, where all evidence would be presented, witness testimony would be given under oath, and an independent group of arbitrators would ultimately decide the outcome of the case.
"USADA will continue to follow the established procedures that are compliant with federal law and were approved by athletes, the US Olympic Committee, and all Olympic sports organisations."
An arbitration panel will now rule on the case.
Armstrong, 40, has always strenuously denied all allegations of doping. Armstrong survived testicular cancer early in his career and went on to win seven consecutive Tour de France titles from 1999 to 2005. He retired after the 2005 Tour de France, but returned in 2009 before retiring for a second time in February 2011.